Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Open-label Extension Study to Investigate the Long-term Safety and Efficacy of IgPro20 in Maintenance Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Subjects Completing Study IgPro20_3003

NCT02027701 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT02027701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02027701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Open-label Extension Study to Investigate the Long-term Safety and Efficacy of IgPro20 in Maintenance Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Subjects Completing Study IgPro20_3003
Lead sponsor
CSL Behring
Phase
Phase 3
Overall status
Completed
Start date
July 30, 2014
Completion date
July 10, 2017
Enrollment
82 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

chronic inflammatory demyelinating polyneuropathy (cidp), polyradiculoneuropathy, chronic inflammatory demyelinating